GlaxoSmithKline granted FDA approval for drug to treat multiple myeloma By: Philadelphia Business Journal via Business Journals August 06, 2020 at 11:19 AM EDT GlaxoSmithKline said the treatment was granted an accelerated approval based on patient response rate in clinical trials. Read More >>